Evidence map›Paper›PMID 41365875›Full record

ArticleNature communications2025

Epigenetic regulation of cocaine intake through dopaminergic control of cholinergic interneurons in male mice.

Robert G Lewis, Lauren Otsuka, Daniela Punzo, Yasmine Sherafat, Ermanno Florio, Mingqi Zhou, Valeria Lallai, Thu Dinh Nha Pham, Marcus Seldin, Christie D Fowler and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Robert G Lewis *INSERM U1233, Center for Epigenetics and Metabolism, University of California, Irvine, CA, USA.ORCID http://orcid.org/0000-0002-3709-3170
Lauren Otsuka *INSERM U1233, Center for Epigenetics and Metabolism, University of California, Irvine, CA, USA.
Daniela PunzoINSERM U1233, Center for Epigenetics and Metabolism, University of California, Irvine, CA, USA.
Yasmine SherafatDepartment of Neurobiology and Behavior, University of California, Irvine, CA, USA.
Ermanno FlorioINSERM U1233, Center for Epigenetics and Metabolism, University of California, Irvine, CA, USA.
Mingqi ZhouDepartment of Biological Chemistry, University of California, Irvine, CA, USA.ORCID http://orcid.org/0009-0007-7643-7873
Valeria LallaiDepartment of Neurobiology and Behavior, University of California, Irvine, CA, USA.
Thu Dinh Nha PhamINSERM U1233, Center for Epigenetics and Metabolism, University of California, Irvine, CA, USA.
Marcus SeldinDepartment of Biological Chemistry, University of California, Irvine, CA, USA.ORCID http://orcid.org/0000-0001-8026-4759
Christie D FowlerDepartment of Neurobiology and Behavior, University of California, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-2864-2163
Emiliana BorrelliINSERM U1233, Center for Epigenetics and Metabolism, University of California, Irvine, CA, USA. borrelli@uci.edu.ORCID http://orcid.org/0000-0002-1813-2541

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
Uncover Strategies Used By Biological SystemsP50GM076516 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI NIE, QING · 2007 to 2016
$25.1M
Circulating miRNAs and Epigenetic Regulation in Nicotine AddictionDP1DA039658 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI FOWLER, CHRISTIE D · 2015 to 2019
$2.3M
Training Program in Substance Use and Use DisordersT32DA050558 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI WOOD, MARCELO ANDRES · 2020 to 2024
$892k
Drugs of abuse, Dopamine and the Circadian Clock: a Metabolomic StudyR21DA035600 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BORRELLI, EMILIANA, SASSONE-CORSI, PAOLO · 2013 to 2014
$617k
Role of the Nicotinic Receptor Modulator Lynx1 in Nicotine DependenceF31DA050436 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SHERAFAT, YASMINE · 2020 to 2020
$40k
NCI NIH HHS P30 CA062203NIDA NIH HHS DP1 DA039658NIDA NIH HHS F31 DA050436NIDA NIH HHS R21 DA035600NIDA NIH HHS T32 DA050558NIGMS NIH HHS P50 GM076516U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DA035600U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DA039658U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DA050436U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DA050558
6 · The paper itself

Abstract

Substance use disorders are chronic neuropsychiatric conditions influenced by multiple factors, shaping individuals' vulnerability to addictive drugs like cocaine. Here, we reveal that dopamine D2 receptor mediated inhibition of striatal cholinergic interneurons regulates the motivation for cocaine intake by modulating acetylcholine signaling in striatal circuits. This acetylcholine-dependent mechanism contributes to cocaine self-administration through the muscarinic M4 receptor and the histone acetyltransferase Kat5/Tip60. We discover that Kat5 is upregulated in response to cocaine and further show that this leads to acetylation of histone H4 on lysine 8, an epigenetic modification that increases immediate early gene expression and muscarinic M4 receptor in dopamine D1 receptor-expressing medium spiny neurons. Notably, this chain of events is absent in male mice lacking D2 receptor-mediated inhibition of cholinergic interneurons, resulting in reduced cocaine consumption. These findings expand our understanding of how cocaine manipulates striatal circuits to reinforce drug-seeking behavior.

Indexed as

Cholinergic NeuronsCocaineCocaine-Related DisordersEpigenesis, GeneticInterneuronsAcetylationAcetylcholineAnimalsCorpus StriatumDopamineHistonesMaleMiceMice, Inbred C57BLMice, KnockoutReceptor, Muscarinic M4AcetylcholineCocaineDopamineHistonesReceptor, Muscarinic M4Receptors, Dopamine D1Receptors, Dopamine D2

Identifiers

PMID41365875
PMCPMC12689792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.